Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis

Abstract

Our study implies that albendazole can act as a potent agonist of LRRN3 during fibroblast to myofibroblast differentiation and its oral administration shows potential as a viable therapeutic approach for managing IPF.